This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suzhou Prajna Biotech Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Rebecca Hu: Innovator in Anti-Cancer Therapies
Introduction
Rebecca Hu is a prominent inventor based in Foster City, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods. Her work focuses on utilizing gut microbiota and oncolytic viruses to enhance anti-tumor responses.
Latest Patents
Rebecca Hu holds a patent for "Anti-cancer oncolytic virus combination therapies and elite responder selection platforms." This patent outlines therapeutic methods for administering gut microbiota and oncolytic viruses to a subject. The gut microbiota serve to pre-condition the subject's immune system to antitumor responses and augment the anticancer activity of the oncolytic virus. The patent also discusses combinations of gut microbiota and viruses for treating and preventing cancer.
Career Highlights
Rebecca is associated with Suzhou Prajna Biotech Co., Ltd., where she continues to advance her research in cancer therapies. Her innovative approach has positioned her as a key player in the biotechnology sector.
Collaborations
Rebecca collaborates with notable colleagues, including Yu Jin Li and Minjie Hu, who contribute to her research efforts and enhance the impact of her work.
Conclusion
Rebecca Hu's contributions to anti-cancer therapies through her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly improve cancer treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile